Advances in Traditional Medicine

Kyung Hee Oriental Medicine Research Center (경희대학교 융합한의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

In vitro response of rat microglia and human polymorphonuclear cells (PMN) to immunoactive compounds

  • Published : 2005.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Although the field of study in immune enhancing compounds is relatively new, natural products from plants represent a rich and promising source of novel molecules with immunomodulating properties, Microglial cells, the main immune effector cells of the brain, usually display a ramified morphology and low expression levels of immunologically relevant antigens such as MHC class I and class II. Since any compound which participates in activation of phagocytic cells contributes to the production of potentially toxic factors, the search for convenient in vitro test-systems and study of mechanisms of action of these agents are of great interest. Human blood polymorphonuclear (PMN) cells and primary microglial cells isolated from Sprague-Dawley rats were used as cellular screening tests for study of phagocytosis-stimulating action of immunomodulating agents. Numbers of phagocytic activity were evaluated by the phagocyte ingestion of yeast cells and NO-synthase activity, nitrite production, and nitroblue tetrazolium test were determined after phagocyte stimulation. It was possible to demonstrate that indexes of phagocytic activity can be used as quantitative indicators for measurement immunomodulating activity. As a positive control, Zymosan A-induced phagocytosis in both PMN cells and primary microglial cells was used. $IFN-{\gamma}$ (0.1 -1 U/ml) stimulated phagocytosis in PMN cells 1.2 times after 2 - 3 h incubation, although at higher concentrations (10 - 100 U/ml) it strongly inhibited phagocytosis. In a similar way, at higher concentrations, $IFN-{\gamma}$ (100 - 500 U/ml) suppressed phagocytosis in zymosan-A stimulated microglial cells. When Polypodium leucotomus, cambricum and vulgare extracts were tested alone, increased levels of phagocytosis were observed in PMN. In addition, microglial cells showed both increased phagocytosis and MHC class-II antigen expressions. Surprisingly, when PMN and microglia were treated with a combination of Polypodium and $IFN-{\gamma}$, phagocytosis was not inhibited. We did not find changes in NO-synthase activity and nitrite production in both microglia and PMN cells activated by different immunomodulating agents. These results indicate that primary microglial cell cultures as well as human PMN cells can provide reproducible quantitative results in screening phagocytic activity of different immunoactive compounds. Furthermore, both inhibitory or activation mechanisms might be studied using these in vitro experimental approaches.

Keywords

References

  1. Aktan F. (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci. 75, 639-653. https://doi.org/10.1016/j.lfs.2003.10.042
  2. Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. (2004) Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 18, 377-390.
  3. Alvarez XA, Pichel V, Perez P, Laredo M, Corzo D, Zas R, Fernandez-Novoa L, Sempere JM, Diaz J, Cacabelos R. (2000) Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics. Meth. Find. Exp. Clin. Pharmacol. 22, 585-594.
  4. Ananth C, Gopalakrishnakone P, Kaur C. (2003) Induction of inducible nitric oxide synthase expression in activated microglia following domoic acid (DA)-induced neurotoxicity in the rat hippocampus. Neurosci. Lett. 338, 49-52. https://doi.org/10.1016/S0304-3940(02)01351-4
  5. Arias-Negrete S, Jimenez-Romero LA, Solis-Martinez MO, Ramirez-Emiliano J, Avila EE, Cuellar-Mata P. (2004) Indirect determination of nitric oxide production by reduction of nitrate with a freezethawing-resistant nitrate reductase from Escherichia coli MC1061. Anal. Biochem. 328, 14-21. https://doi.org/10.1016/j.ab.2004.01.026
  6. Ayoub AE, Salm AK. (2003) Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus. J. Neurosci. 23, 7759-7766. https://doi.org/10.1523/JNEUROSCI.23-21-07759.2003
  7. Bernd A, Ramirez-Bosca A, Huber H, Diaz Alperi J, Thaci D, Sewell A, Quintanilla Almagro E, Holzmann H. (1995) In vitro studies on the immunomodulating effects of polypodium leucotomos extract on human leukocyte fractions. Arzneimittel-forsch. 45, 901-904.
  8. Brigneti G, Martin-Hernandez AM, Jin H, Chen J, Baulcombe DC, Baker B, Jones JD. (2004) Virus-induced gene silencing in Solanum species. Plant J. 39, 264-272. https://doi.org/10.1111/j.1365-313X.2004.02122.x
  9. Cacabelos R, Alvarez A Fernandez-Novoa L, Lombardi VR. (2000) A pharmacogenomic approach to Alzheimer's disease. Acta Neurol. Scand. Suppl. 176, 12-19.
  10. Chavarria A, Alcocer-Varela J. (2004) Is damage in central nervous system due to inflammation? Autoimmun. Rev. 3, 251-260. https://doi.org/10.1016/j.autrev.2003.09.006
  11. Chiang LC, Ng LT, Chiang W, Chang MY, Lin CC. (2003) Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 69, 600-604. https://doi.org/10.1055/s-2003-41113
  12. Cooke JP. (2004) The pivotal role of nitric oxide for vascular health. Can. J. Cardiol. Suppl B, 7B-15B.
  13. Eisenstein TK. (2001) Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Microbes Infect. 3, 1223-1231. https://doi.org/10.1016/S1286-4579(01)01482-4
  14. Eskes C, Juillerat-Jeanneret L, Leuba G, Honegger P, Monnet-Tschudi F. (2003) Involvement of microglianeuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J. Neurosci. Res. 71, 583-590. https://doi.org/10.1002/jnr.10508
  15. Etkin NL. (2003) The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria. Proc. Nutr. Soc. 62, 311-317. https://doi.org/10.1079/pns2003244
  16. Fornoni J, Nunez-Farfan J, Valverde PL, Rausher MD. (2004) Evolution of mixed strategies of plant defense allocation against natural enemies. Evolution Int. J. Org. Evolution 58, 1685-1695. https://doi.org/10.1111/j.0014-3820.2004.tb00454.x
  17. Garden GA. (2002) Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40, 240-251.
  18. Goldstein DA, Thomas JA. (2004) Biopharmaceuticals derived from genetically modified plants. Q.J.M. 97, 705-716.
  19. Guillemin GJ, Brew BJ. (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75, 388-397. https://doi.org/10.1189/jlb.0303114
  20. Hart SP, Alexander KM, Dransfield I. (2004) Immune complexes bind preferentially to Fc gamma RIIA (CD32) on apoptotic neutrophils, leading to augmented phagocytosis by macrophages and release of proinflammatory cytokines. J. Immunol. 172, 1882-1887. https://doi.org/10.4049/jimmunol.172.3.1882
  21. Jiang F, Dusting GJ. (2003) Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Curr. Vasc. Pharmacol. 1, 135-156. https://doi.org/10.2174/1570161033476736
  22. Jurado S, Sanchez-Prieto J, Torres M. (2004) Elements of the nitric oxide/cGMP pathway expressed in cerebellar granule cells: biochemical and functional characterisation. Neurochem. Int. 45, 833-843. https://doi.org/10.1016/j.neuint.2004.03.013
  23. Kawakami K, Kawakami M, Puri RK. (2004) Nitric oxide accelerates interleukin-13 cytotoxin-mediated regression in head and neck cancer animal model. Clin. Cancer Res. 10, 5264-5270. https://doi.org/10.1158/1078-0432.CCR-04-0314
  24. Kawashima K, Fujii T. (2004) Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 9, 2063-2085. https://doi.org/10.2741/1390
  25. Kitajima M, Hashimoto K, Sandoval M, Aimi N, Takayama H. (2004) New oleanan-type triterpene and cincholic acid glycosides from Peruvian "Una de Gato" (Uncaria tomentosa). Chem. Pharm. Bull. 52, 1258-1261. https://doi.org/10.1248/cpb.52.1258
  26. Kitajima M, Hashimoto K, Yokoya M, Takayama H, Sandoval M, Aimi N. (2003) Two new nortriterpene glycosides from peruvian "Una de Gato" (Uncaria tomentosa). J. Nat. Prod. 66, 320-323. https://doi.org/10.1021/np0203741
  27. Kobayashi SD, Voyich JM, DeLeo FR. (2003) Regulation of the neutrophil-mediated inflammatory response to infection. Microbes Infect. 14, 1337-1344.
  28. Lombardi VRM, Etcheverria I, Fernandez-Novoa L, Blanco A, Diaz J, Cacabelos R. (2003) Extracts from Polypodium ferns upregulate the expresion of CD95 in human peripheral blood lymphocytes. Orient. Pharm. Exp. Med. 3, 90-99. https://doi.org/10.3742/OPEM.2003.3.2.090
  29. Magnus T, Korn T, Jung S. (2004) Chronically stimulated microglial cells do no longer alter their immune functions in response to the phagocytosis of apoptotic cells. J. Neuroimmunol. 155, 64-72. https://doi.org/10.1016/j.jneuroim.2004.06.002
  30. Maneiro E, Lombardi VRM, Cacabelos R. (1996) Rat cell cultures: experimental models to study neurodegenerative disorders and new pharmacological compounds. Meth. Find. Exp. Clin. Pharmacol. 18, 615-645.
  31. Mariotto S, Menegazzi M, Suzuki H. (2004) Biochemical aspects of nitric oxide. Curr. Pharm. Des. 10, 1627-1645. https://doi.org/10.2174/1381612043384637
  32. Marsili V, Calzuola I, Gianfranceschi GL. (2004) Nutritional relevance of wheat sprouts containing high levels of organic phosphates and antioxidant compounds. J. Clin. Castroenterol. 38, S123-S126. https://doi.org/10.1097/01.mcg.0000128933.46296.0a
  33. Mills EI, Quie PG. (1981) Metabolic activity of granulocytes in phagocytosis. In: SD Douglas, PG Quie ed. Investigation of phagocytosis in clinics. Churchill Livingstone: Edimbourgh, London, Melburne, and New York 78-91.
  34. Parejo I, Caprai E, Bastida J, Viladomat F, Jauregui 0, Codina C. (2004) Investigation of Lepechinia graveolens for its antioxidant activity and phenolic composition. J. Ethnopharmacol. 94, 175-184. https://doi.org/10.1016/j.jep.2004.05.017
  35. Ramani AK, Marcotte EM. (2003) Exploiting the coevolution of interacting proteins to discover interaction specificity. J. Mol. Biol. 327, 273-284. https://doi.org/10.1016/S0022-2836(03)00114-1
  36. Rates SM. (2001) Plants as source of drugs. Toxicon. 39, 603-613. https://doi.org/10.1016/S0041-0101(00)00154-9
  37. Rose JW, Hill KE, Watt HE, Carlson NG. (2004) Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion. J. Neuroimmunol. 149, 40-49. https://doi.org/10.1016/j.jneuroim.2003.12.021
  38. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R. (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 183, 25-33. https://doi.org/10.1016/S0014-4886(03)00082-7
  39. Sears CE, Ashley EA, Casadei B. (2004) Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359, 1021-1044. https://doi.org/10.1098/rstb.2004.1477
  40. Sharif MN, Tassiulas I, Hu Y, Mecklenbrauker I, Tarakhovsky A, Ivashkiv LB. (2004) IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J. Immunol. 172, 6476-6481. https://doi.org/10.4049/jimmunol.172.10.6476
  41. Simard AR, Rivest S. (2004) Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18, 998-1000. https://doi.org/10.1096/fj.04-1517fje
  42. Song X, Ianaka S, Cox D, Lee SC. (2004) Fcgamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J. Leukoc. Biol. 75, 1147-1155. https://doi.org/10.1189/jlb.0403128
  43. Streit WJ. (2004) Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 77, 1-8. https://doi.org/10.1002/jnr.20093
  44. Streit WJ, Mrak RE, Griffin WS. (2004) Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 1, 14. https://doi.org/10.1186/1742-2094-1-14
  45. Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Iakasuka N, Moore MA. (2004) Cancer prevention by natural compounds. Drug Metab. Pharmacokinet. 19, 245-263. https://doi.org/10.2133/dmpk.19.245
  46. Ulfig N, Bohl J, Neudorfer F, Rezaie P. (2004) Brain macrophages and microglia in human fetal hydrocephalus. Brain Dev. 26, 307-315. https://doi.org/10.1016/S0387-7604(03)00172-4
  47. Urios A, Lopez-Gresa MP, Gonzalez MC, Primo J, Martinez A, Herrera G, Escudero JC, O'Coilleor JE, Blanco M. (2003) Nitric oxide promotes strong cytotoxicity of phenolic compounds against Escherichia coli: the influence of antioxidant defenses. Free Radic. Biol. Med. 35, 1373-1381. https://doi.org/10.1016/j.freeradbiomed.2003.08.007
  48. van der Veen RC, Dietlin TA, Karapetian A, Holland SM, Hofman FM. (2004) Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide. J. Neuroimmunol. 153, 183-189. https://doi.org/10.1016/j.jneuroim.2004.05.008
  49. Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, Lucius R. (2003) Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 17, 500-502. https://doi.org/10.1096/fj.02-0314fje
  50. Woolhouse ME, Webster JP, Domingo E, Charlesworth B, Levin BR. (2002) Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 32, 569-577. https://doi.org/10.1038/ng1202-569
  51. Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, Simpson EP, Yen AA, Xiao Q, Appel SH. (2004) Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J. Neuropathol. Exp. Neurol. 63, 964-977. https://doi.org/10.1093/jnen/63.9.964